StreetInsider.com News Articles

Form 8-K FEMASYS INC For: Jun 24

Wed, 24 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260624/26685538.html

Form 8-K FEMASYS INC For: Jun 24

Wed, 24 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260624/26685538.html

Form 8-K FEMASYS INC For: Jun 23

Wed, 24 Jun 2026 09:36:00 -0400

si-local-file:///var/storage/secattach/20260624/26683376.html

Form 8-K FEMASYS INC For: Jun 23

Wed, 24 Jun 2026 09:36:00 -0400

si-local-file:///var/storage/secattach/20260624/26683376.html

Femasys regains Nasdaq minimum bid price compliance

Wed, 24 Jun 2026 09:00:22 -0400

Femasys Inc. (NASDAQ: FEMY) announced it received formal notice from The Nasdaq Stock Market LLC confirming the company has regained compliance with Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing on the exchange.

Nasdaq confirmed the matter is now closed, according to a press release from the Atlanta-based biomedical company.

Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys, said, "Regaining compliance with Nasdaq's continued listing requirements is an important development for Femasys and our shareholders. With this matter now closed, we remain focused on advancing our strategic priorities, expanding access to our innovative reproductive health solutions and building

Femasys Regains Compliance with Nasdaq Listing Requirements

Wed, 24 Jun 2026 09:00:00 -0400

ATLANTA, June 24, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator focused on making fertility and non-surgical permanent birth control more accessible and cost-effective for women worldwide, announced today that it received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) confirming the Company has regained compliance with Listing Rule 5550(a)(2), the minimum bid price requirement for continued listing and that the matter is now closed.

Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys, stated, “Regaining compliance with Nasdaq’s continued listing requirements is an important development for Femasys

Femasys Regains Compliance with Nasdaq Listing Requirements

Wed, 24 Jun 2026 09:00:00 -0400

Kathy Lee-Sepsick, Chief Executive Officer and Founder of Femasys, stated, “Regaining compliance with Nasdaq’s continued listing requirements is an important development for Femasys

Form 8-K FEMASYS INC For: Jun 05

Fri, 05 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260605/26611041.html

Form 8-K FEMASYS INC For: Jun 05

Fri, 05 Jun 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260605/26611041.html

Form 8-K FEMASYS INC For: Jun 04

Thu, 04 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260604/26603331.html

Form 8-K FEMASYS INC For: Jun 04

Thu, 04 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260604/26603331.html

Form 8-K FEMASYS INC For: May 13

Wed, 13 May 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260513/26487093.html

Form 8-K FEMASYS INC For: May 13

Wed, 13 May 2026 16:48:00 -0400

si-local-file:///var/storage/secattach/20260513/26487093.html

Femasys receives CE mark approval for FemHSG fertility catheter in Europe